These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2502162)

  • 1. A comparison of the efficiency in serotyping of Pseudomonas aeruginosa from cystic fibrosis patients using monoclonal and polyclonal antibodies.
    Ojeniyi B; Lam JS; Høiby N; Rosdahl VT
    APMIS; 1989 Jul; 97(7):631-6. PubMed ID: 2502162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Wolz C; Döring G; Lam JS; Rosdahl VT; Høiby N
    APMIS; 1990 May; 98(5):423-31. PubMed ID: 2113398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of polyclonal rabbit antisera with monoclonal antibodies for serological typing of Pseudomonas aeruginosa.
    Strickland MA; Gaston MA; Pitt TL
    J Clin Microbiol; 1988 Apr; 26(4):768-9. PubMed ID: 3130391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Høiby N; Rosdahl VT
    APMIS; 1991 Jun; 99(6):492-8. PubMed ID: 1905144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype and serum sensitivity of Pseudomonas aeruginosa from children with cystic fibrosis: longitudinal studies and typing with monoclonal antibodies.
    Burke V; Richardson CJ; Robinson J
    Pathology; 1990 Oct; 22(4):223-6. PubMed ID: 2128649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.
    Hancock RE; Mutharia LM; Chan L; Darveau RP; Speert DP; Pier GB
    Infect Immun; 1983 Oct; 42(1):170-7. PubMed ID: 6413410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis.
    Pitt TL; MacDougall J; Penketh AR; Cooke EM
    J Med Microbiol; 1986 Mar; 21(2):179-86. PubMed ID: 2419563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serotype caused by cell to cell contact between different Pseudomonas aeruginosa strains from cystic fibrosis patients.
    Ojeniyi B; Rosdahl VT; Høiby N
    Acta Pathol Microbiol Immunol Scand B; 1987 Feb; 95(1):23-7. PubMed ID: 3105245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subdivision of O serotypes of Pseudomonas aeruginosa with monoclonal antibodies.
    Vale TA; Gaston MA; Pitt TL
    J Clin Microbiol; 1988 Sep; 26(9):1779-82. PubMed ID: 3141466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotyping of Pseudomonas aeruginosa isolated from clinical specimens.
    Kono M; Sei S
    Jpn J Exp Med; 1977 Feb; 47(1):1-7. PubMed ID: 404450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.
    Fomsgaard A; Conrad RS; Galanos C; Shand GH; Høiby N
    J Clin Microbiol; 1988 May; 26(5):821-6. PubMed ID: 3133386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and persistence of polyagglutinable Pseudomonas aeruginosa in isolates from cystic fibrosis patients.
    Ojeniyi B; Høiby N; Rosdahl VT
    APMIS; 1991 Feb; 99(2):187-95. PubMed ID: 1900422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of monoclonal antibodies to Pseudomonas aeruginosa isolates from hospitalized adults and patients with cystic fibrosis.
    Torensma R; Fluit AC; Verhoef J
    Clin Infect Dis; 1994 Jul; 19(1):11-4. PubMed ID: 7948511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. The International Pseudomonas aeruginosa Typing Study Group.
    J Infect Dis; 1994 Jan; 169(1):134-42. PubMed ID: 7903973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotyping of Pseudomonas aeruginosa from patients with cystic fibrosis of the pancreas.
    Hirao Y; Homma JY; Zierdt CH
    Jpn J Exp Med; 1977 Aug; 47(4):249-54. PubMed ID: 411970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Petersen US; Høiby N
    APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.
    Brokopp CD; Gomez-Lus R; Farmer JJ
    J Clin Microbiol; 1977 Jun; 5(6):640-9. PubMed ID: 407246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera.
    Pitt TL; Erdman YJ
    J Med Microbiol; 1978 Feb; 11(1):15-23. PubMed ID: 413923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa clinical isolates: serotypes, resistance phenotypes and plasmid profiles.
    Millesimo M; de Intinis G; Chirillo MG; Musso T; Savoia D
    Eur J Epidemiol; 1996 Apr; 12(2):123-9. PubMed ID: 8817189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.